Search

Your search keyword '"Sediva, A"' showing total 1,202 results

Search Constraints

Start Over You searched for: Author "Sediva, A" Remove constraint Author: "Sediva, A"
1,202 results on '"Sediva, A"'

Search Results

152. Human genetic and immunological determinants of critical COVID-19 pneumonia

153. Synthesis, characterization and water electrolyzer cell tests of poly(biphenyl piperidinium) Anion exchange membranes

156. An immunologist's perspective on anti-COVID-19 vaccines

157. (Summary of consesus statement on the management of patients with implantable pacemakers and cardioverter-defibrillators undergoing radiotherapy)

158. Expanded population of lowdensity neutrophils in juvenile idiopathic arthritis.

159. B cell phenotype and serum levels of interferons, BAFF, and APRIL in multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C).

160. Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis

161. Autoantibodies against type I IFNs in patients with critical influenza pneumonia

162. Immunomodulation of neutrophils and platelets by TNF blockage in patients with juvenile idiopathic arthritis

163. Aberrant tolerogenic functions and proinflammatory skew of dendritic cells in STAT1 gain-of-function patients may contribute to autoimmunity and fungal susceptibility

164. Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics

165. Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency

166. Facile Poly(ethyl-ketone) Chemical Functionalization for Anion Exchange Membranes

167. PATIENT-CENTRED SCREENING FOR PRIMARY IMMUNODEFICIENCY, A MULTI-STAGE DIAGNOSTIC PROTOCOL DESIGNED FOR NONIMMUNOLOGISTS: 2011 UPDATE

168. Microbiota, Microbial Metabolites, and Barrier Function in A Patient with Anorexia Nervosa after Fecal Microbiota Transplantation

169. Allergic diseases and immunodeficiencies in children, lessons learnt from COVID ‐19 pandemic by 2022: A statement from the EAACI ‐section on pediatrics

173. Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency

178. High Prevalence of Likely Passively Acquired Anti-TPO and Anti-GAD Autoantibodies in Common Variable Immunodeficiency

179. Left atrial thickness and acute thermal injury in patients undergoing ablation for atrial fibrillation: Laser versus radiofrequency energies

180. Clinical Outcomes, Immunogenicity, and Safety of BNT162b2 Vaccine in Primary Antibody Deficiency

181. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

182. B cells, BAFF and interferons in MIS-C

183. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

184. A Man as the Regulator in Man-Machine Systems

190. Evaluating the Redox Behavior of Doped Ceria for Thermochemical CO2 Splitting Using Time-Resolved Raman Spectroscopy

195. B cells, BAFF and interferons in MIS-C

200. PO-682-04 IMPACT OF PULSED FIELD ABLATION FOR ATRIAL FIBRILLATION ON THE CARDIAC AUTONOMIC NERVOUS SYSTEM

Catalog

Books, media, physical & digital resources